Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:55 AM
Ignite Modification Date:
2025-12-25 @ 4:55 AM
NCT ID:
NCT04469218
Eligibility Criteria:
Inclusion Criteria:
* All patients admitted into the participating hospital units
* Patients of any gender may participate
* Participants able to provide informed consent or have a legally authorized representative immediately available to provide informed consent
* Patients must have peripheral IV catheter access or need and are planned to have peripheral IV catheter access placed that is anticipated to last a minimum of 24 hours.
* Patients must be receiving intermittent or continuous infusion or have immediate plans to begin an intermittent or continuous infusion
* The patients must be at least 18 years of age with no upper age limit
Exclusion Criteria:
* Unable to obtain informed consent or without an available Legally Authorized Representative or Next of Kin to provide surrogate informed consent
* Age less than or equal to 17
* Patient on comfort care only
* Predicted to have an IV infusion that lasts less than 24 hours
* Patient admitted from the Emergency Department refuses to have new peripheral IV catheter placed by IV team
* Patient has two or more peripheral IV catheters at the same time
* Patient enrolled in a subject drug or device study at the time of enrollment
* Investigator discretion that patient is not suitable for the study
* Patient is COVID-19 positive
* Patient is receiving an IV infusion with gravity tubing
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04469218
Study Brief:
Protocol Section:
NCT04469218